Low-dose preoperative pregabalin improves postoperative pain management in septorhinoplasty surgery: a double-blind randomized clinical trial.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 08 12 2018
accepted: 23 04 2019
pubmed: 6 5 2019
medline: 19 11 2019
entrez: 6 5 2019
Statut: ppublish

Résumé

To evaluate the efficacy of single low dose (75 mg) preoperative pregabalin in reducing post-operative pain of septorhinoplasty. A double blind single center Randomized controlled trial based on block randomization. In the pregabalin group (PG) 34 participants received 75 mg pregabalin orally one hour before anesthesia induction while in control group (CG) 34 participants received a placebo. Pain and sedation were repeatedly measured with Visual Analouge Scale (VAS) and Riker Sedation-Agitation Scale (RSAS) respectively, 0.5, 1, 2, 6, 24 hours postextubation. Cumulative doses of fentanyl and ibuprofen received in both groups were compared. Thirty-two of the participants in PG and 33 of the participants in CG completed the study. The Mean VAS pain score was less in PG versus CG 30 min postoperatively (2.30 ± 1.30 vs. 4.85 ± 1.17), one hour (2.28 ± 0.92 vs. 4.27 ± 0.78), two hours (2.11 ± 0.88 vs. 3.60 ± 0.61) and six hours (1.47 0.62 vs. 2.76 ± 0.91) but not 24-hours postoperatively (0.84 ± 0.62 vs. 1.09 ± 0.92). Participants in the PG were less agitated during early post-extubation period (at 10 min: RSAS 3.93 ± 0.43 vs. 4.42 ± 0.50) and more alert during the first hour post-extubation (at 60 min: RSAS 3.90 ± 0.29 vs. 3.36 ± 0.69). The total dose of rescue fentanyl and ibuprofen was lower in the PG compared to the CG. A single dose of 75 mg pregabalin is very effective for pain control after septorhinoplasty procedure when administered one hour before anesthesia induction. Side effects are rare and opioid sparing was noted. Clinical trial number: IRCT2017043033706N1.

Identifiants

pubmed: 31055640
doi: 10.1007/s00405-019-05448-y
pii: 10.1007/s00405-019-05448-y
doi:

Substances chimiques

Analgesics 0
Analgesics, Opioid 0
Pregabalin 55JG375S6M
Fentanyl UF599785JZ
Ibuprofen WK2XYI10QM

Banques de données

IRCT
['IRCT2017043033706N1']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

2243-2249

Références

Crit Care. 2008;12(1):R15
pubmed: 18279522
Anesth Analg. 2004 Aug;99(2):375-8, table of contents
pubmed: 15271709
Anesth Analg. 2009 Apr;108(4):1140-5
pubmed: 19299776
J Fla Med Assoc. 1996 Dec;83(10):695-700
pubmed: 9019059
Pain Res Treat. 2014;2014:850794
pubmed: 24876957
J Craniofac Surg. 2013 Mar;24(2):373-5
pubmed: 23524696
Laryngoscope. 2016 Oct;126(10):2232-41
pubmed: 26925956
Expert Opin Investig Drugs. 2003 Apr;12(4):663-72
pubmed: 12665421
Aesthetic Plast Surg. 2013 Dec;37(6):1100-6
pubmed: 24057811
J Pediatr Hematol Oncol. 2015 Apr;37(3):190-4
pubmed: 25575295
Int Clin Psychopharmacol. 2017 Jan;32(1):49-55
pubmed: 27643884
Rheumatol Int. 2013 Oct;33(10):2617-23
pubmed: 23736275
J Laryngol Otol. 2010 Nov;124(11):1194-9
pubmed: 20602848
Eur Arch Otorhinolaryngol. 2012 Jun;269(6):1613-21
pubmed: 22130915
J Clin Pharmacol. 2010 Aug;50(8):941-50
pubmed: 20147618
N Engl J Med. 2010 Dec 30;363(27):2638-50
pubmed: 21190458
Medicine (Baltimore). 2015 Nov;94(46):e1944
pubmed: 26579802
Anesth Analg. 1993 Nov;77(5):1048-56
pubmed: 8105724
Clin Exp Otorhinolaryngol. 2014 Jun;7(2):102-5
pubmed: 24917905
J Neurosci. 2001 Jan 1;21(1):279-86
pubmed: 11150345
Epilepsia. 2004;45 Suppl 6:13-8
pubmed: 15315511

Auteurs

Pejman Pourfakhr (P)

Department of Anesthesiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Reza Khajavi (MR)

Department of Anesthesiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Ali Jalali (A)

Department of Anesthesiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. a.jalali.md@gmail.com.

Faramarz Memari (F)

Department of Otology/Neurotology, Erfan Hospital, Tehran, Iran.

Farhad Etezadi (F)

Department of Anesthesiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mehrnoush Momeni Roochi (M)

Department of Oral and Maxillofacial Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Reza Shariat Moharari (R)

Department of Anesthesiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Atabak Najafi (A)

Department of Anesthesiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH